{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-084650","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.237235+00:00","generated_at":"2026-05-19T13:23:40.309579+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Iterum Therapeutics enters commercialization agreement with EVERSANA for ORLYNVAH in US","bullets":["Eversana will be exclusive provider of sales, marketing, logistics, regulatory, and medical affairs services for ORLYNVAH.","ITUS retains legal, regulatory, manufacturing, and books sales; pays fees and expenses per statements of work.","Term is 5 years from commercial launch; either party can terminate for material breach, insolvency, or certain law changes.","ITUS or change-of-control counterparty may terminate upon paying specified fees; Eversana can terminate if ORLYNVAH is withdrawn.","Agreement includes customary confidentiality, indemnification, and liability limitations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-084650","json":"https://secwatch.observer/filing/0000950170-25-084650.json","markdown":"https://secwatch.observer/filing/0000950170-25-084650.md","text":"https://secwatch.observer/filing/0000950170-25-084650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000095017025084650/0000950170-25-084650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000095017025084650/itrm-20250606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:23:40.309579+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}